ecancermedicalscience

Review

Role of traditional and new biomarkers in breast carcinogenesis

29 Oct 2009
D Macis, M Cazzaniga, A De Censi, B Bonanni

In recent decades, several biomarkers have been investigated as predictors of breast cancer risk, development, prognosis and treatment efficacy.

The detection of biomarkers strongly associated with breast carcinogenesis has an enormous potential, especially for selecting subjects at high risk of developing breast cancer who could benefit from chemopreventive treatments.

Although the number of potential biomarkers continues to increase, a unique biomarker for breast cancer risk prediction has not been identified and it is probable that a panel of biomarkers will prove optimal. Further studies are needed to validate breast cancer biomarkers evaluation for individual risk assessment.

This review summarises the main biomarkers, which are important at different stages of breast carcinogenesis with updates from the recent literature.

Related Articles

Afusat O Oduwoye, Elisha O Olabisi, Elizabeth F Ojo, Taiwo O Dosumu, Michael O Owoeye, Adelani Tijani, Deborah T Esan
Yanet Isabel Carrasco Rojas, Albert Gabriel Turpo Peqqueña, Natalia Camila Zenteno Tejada, Victoria Elena Quispe Pastor, Juan Augusto Martínez San Martín, Evelyn Maria Chambilla Huellcacure
Joaquin Fernandez-Alberti, Alex R Villaalta López, Guillermo Scolari, Alejandro Iotti, Marcelo Featherston
Izaberen Sampaio Estevam, Mariana Macambira Noronha, Júlia Matos Dubanhevitz, Eric Lima Freitas Mota, Ígor Giordan Duarte Jorge, Conceição Aparecida Dornelas, Diane Isabelle Magno Cavalcante, Georgia Fiuza Alencar Araripe, Márcio Marcondes Vieira